199 related articles for article (PubMed ID: 12934116)
21. The relationship between tumor necrosis factor-α, brain natriuretic peptide and atrial natriuretic peptide in patients with chronic heart failure.
Vaz Pérez A; Doehner W; von Haehling S; Schmidt H; Zimmermann AV; Volk HD; Anker SD; Rauchhaus M
Int J Cardiol; 2010 May; 141(1):39-43. PubMed ID: 19155075
[TBL] [Abstract][Full Text] [Related]
22. [Clinical applications of brain natriuretic peptide testing].
Scardovi AB; ; ; ; ;
Ital Heart J Suppl; 2004 May; 5(5):343-56. PubMed ID: 15182061
[TBL] [Abstract][Full Text] [Related]
23. Diagnostic accuracy of natriuretic peptides for acute heart failure: a review.
Zhou SL; Zhang J; Song TT; Li X; Wang HX
Eur Rev Med Pharmacol Sci; 2018 Apr; 22(8):2415-2420. PubMed ID: 29762843
[TBL] [Abstract][Full Text] [Related]
24. B-type natriuretic peptides. A diagnostic breakthrough in heart failure.
McCullough PA
Minerva Cardioangiol; 2003 Apr; 51(2):121-9. PubMed ID: 12783068
[TBL] [Abstract][Full Text] [Related]
25. B-type natriuretic peptide - a biomarker for all seasons?
Mark DB; Felker GM
N Engl J Med; 2004 Feb; 350(7):718-20. PubMed ID: 14960748
[No Abstract] [Full Text] [Related]
26. B-type natriuretic peptide in heart failure.
Colli A; Fraquelli M; Conte D
N Engl J Med; 2002 Dec; 347(24):1976-8; author reply 1976-8. PubMed ID: 12477952
[No Abstract] [Full Text] [Related]
27. Natriuretic peptides in patients with atrial fibrillation and advanced chronic heart failure: determinants and prognostic value of (NT-)ANP and (NT-pro) BNP.
Shelton RJ; Goode K; Cleland JG
Europace; 2007 Feb; 9(2):147; author reply 148. PubMed ID: 17227813
[No Abstract] [Full Text] [Related]
28. Are BNP plasma levels useful in heart failure diagnosis each time? A dyspneic patient with anasarca.
Parrinello G; Torres D; Paterna S; Trapanese C; Pomilla M; Lupo U; Licata G
Am J Emerg Med; 2011 Feb; 29(2):239.e5-239.e10. PubMed ID: 20627214
[No Abstract] [Full Text] [Related]
29. [Measurement of natriuretic peptides].
Harada M; Nakao K
Nihon Rinsho; 2004 Sep; 62 Suppl 9():47-50. PubMed ID: 15506335
[No Abstract] [Full Text] [Related]
30. [Recommendations for the clinical use of cardiac natriuretic peptides].
Emdin M; Clerico A; Clemenza F; Galvani M; Latini R; Masson S; Mulè P; Panteghini M; Valle R; Zaninotto M; Ganau A; Mariotti R; Volpe M; Aspromonte N; Cacciatore G; Cappelletti P; L'Abbate A; Miglio F; Ottani F; Pagani F; Passino C; Plebani M; Sarzani R; Zucchelli G
Ital Heart J Suppl; 2005 May; 6(5):308-25. PubMed ID: 15934430
[No Abstract] [Full Text] [Related]
31. Impact of history of heart failure on diagnostic and prognostic value of BNP: results from the B-type Natriuretic Peptide for Acute Shortness of Breath Evaluation (BASEL) study.
Boldanova T; Noveanu M; Breidthardt T; Potocki M; Reichlin T; Taegtmeyer A; Christ M; Laule K; Stelzig C; Mueller C
Int J Cardiol; 2010 Jul; 142(3):265-72. PubMed ID: 19185372
[TBL] [Abstract][Full Text] [Related]
32. Comparison of midregional pro-atrial natriuretic peptide with N-terminal pro-B-type natriuretic peptide in the diagnosis of heart failure.
Potocki M; Breidthardt T; Reichlin T; Hartwiger S; Morgenthaler NG; Bergmann A; Noveanu M; Freidank H; Taegtmeyer AB; Wetzel K; Boldanova T; Stelzig C; Bingisser R; Christ M; Mueller C
J Intern Med; 2010 Jan; 267(1):119-29. PubMed ID: 19570053
[TBL] [Abstract][Full Text] [Related]
33. [Atrial natriuretic peptide (ANP), brain natriuretic peptide (BNP), C-type natriuretic peptide (CNP)].
Tsujino M; Hirata Y
Nihon Rinsho; 1999 Dec; 57 Suppl():393-7. PubMed ID: 10778147
[No Abstract] [Full Text] [Related]
34. Effect of body mass index on diagnostic and prognostic usefulness of amino-terminal pro-brain natriuretic peptide in patients with acute dyspnea.
Bayes-Genis A; Lloyd-Jones DM; van Kimmenade RR; Lainchbury JG; Richards AM; Ordoñez-Llanos J; Santaló M; Pinto YM; Januzzi JL
Arch Intern Med; 2007 Feb; 167(4):400-7. PubMed ID: 17325303
[TBL] [Abstract][Full Text] [Related]
35. Mid-region pro-hormone markers for diagnosis and prognosis in acute dyspnea: results from the BACH (Biomarkers in Acute Heart Failure) trial.
Maisel A; Mueller C; Nowak R; Peacock WF; Landsberg JW; Ponikowski P; Mockel M; Hogan C; Wu AH; Richards M; Clopton P; Filippatos GS; Di Somma S; Anand I; Ng L; Daniels LB; Neath SX; Christenson R; Potocki M; McCord J; Terracciano G; Kremastinos D; Hartmann O; von Haehling S; Bergmann A; Morgenthaler NG; Anker SD
J Am Coll Cardiol; 2010 May; 55(19):2062-76. PubMed ID: 20447528
[TBL] [Abstract][Full Text] [Related]
36. [Contra: Natriuretic peptides as diagnostic tool. Still obstacles for routine use in heart failure].
Lindstedt G
Lakartidningen; 2006 Mar 22-28; 103(12):930-2, 934-7. PubMed ID: 16618037
[No Abstract] [Full Text] [Related]
37. Recommendations for the use of natriuretic peptides in acute cardiac care: a position statement from the Study Group on Biomarkers in Cardiology of the ESC Working Group on Acute Cardiac Care.
Thygesen K; Mair J; Mueller C; Huber K; Weber M; Plebani M; Hasin Y; Biasucci LM; Giannitsis E; Lindahl B; Koenig W; Tubaro M; Collinson P; Katus H; Galvani M; Venge P; Alpert JS; Hamm C; Jaffe AS;
Eur Heart J; 2012 Aug; 33(16):2001-6. PubMed ID: 21292681
[No Abstract] [Full Text] [Related]
38. [Monitoring heart failure with brain natriuretic peptide].
Sela B
Harefuah; 2003 Jan; 142(1):25-31, 78. PubMed ID: 12647486
[TBL] [Abstract][Full Text] [Related]
39. Questions regarding BNP assays.
Schwam E
Ann Emerg Med; 2006 Feb; 47(2):213-4; author reply 214. PubMed ID: 16431242
[No Abstract] [Full Text] [Related]
40. B-type natriuretic peptide and renal function in the diagnosis of heart failure: an analysis from the Breathing Not Properly Multinational Study.
McCullough PA; Duc P; Omland T; McCord J; Nowak RM; Hollander JE; Herrmann HC; Steg PG; Westheim A; Knudsen CW; Storrow AB; Abraham WT; Lamba S; Wu AH; Perez A; Clopton P; Krishnaswamy P; Kazanegra R; Maisel AS;
Am J Kidney Dis; 2003 Mar; 41(3):571-9. PubMed ID: 12612980
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
